In last trading session, GlycoMimetics Inc (NASDAQ:GLYC) saw 0.34 million shares changing hands with its beta currently measuring 1.83. Company’s recent per share price level of $0.27 trading at -$0.02 or -6.75% at ring of the bell on the day assigns it a market valuation of $17.30M. That closing price of GLYC’s stock is at a discount of -1185.19% from its 52-week high price of $3.47 and is indicating a premium of 48.15% from its 52-week low price of $0.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.26 million shares which gives us an average trading volume of 1.30 million if we extend that period to 3-months.
For GlycoMimetics Inc (GLYC), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
GlycoMimetics Inc (NASDAQ:GLYC) trade information
Upright in the red during last session for losing -6.75%, in the last five days GLYC remained trading in the red while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $0.27 price level, adding 10.0% to its value on the day. GlycoMimetics Inc’s shares saw a change of 7.71% in year-to-date performance and have moved -1.51% in past 5-day. GlycoMimetics Inc (NASDAQ:GLYC) showed a performance of 7.84% in past 30-days. Number of shares sold short was 5.64 million shares which calculate 1.07 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 13.11% during past 5 years.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
Insiders are in possession of 3.12% of company’s total shares while institution are holding 47.91 percent of that, with stock having share float percentage of 49.46%. Investors also watch the number of corporate investors in a company very closely, which is 47.91% institutions for GlycoMimetics Inc that are currently holding shares of the company. BVF INC/IL is the top institutional holder at GLYC for having 9.54 million shares of worth $2.69 million. And as of 2024-06-30, it was holding 14.8071 of the company’s outstanding shares.
The second largest institutional holder is ARTAL GROUP S.A., which was holding about 8.59 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.3252 of outstanding shares, having a total worth of $2.42 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.93 shares of worth $0.52 million or 2.99% of the total outstanding shares. The later fund manager was in possession of 730.6 shares on Sep 30, 2024 , making its stake of worth around $0.2 million in the company or a holder of 1.13% of company’s stock.
